Search Results for: cirm

Keys to successful stem cell translation – Nurses, physicians and patient advocates

/
Adrienne-Bell-Cors

Editor’s note: this is a guest post on stem cell translation. By Heather Main I recently attended the UCSD Health CIRM Alpha Stem Cell Clinics Network Symposium at the Sanford Consortium, San Diego. There was of course some great academic research presented, including conflicting views on liver stem cell compartments from Roel Nusse and David […]

Keys to successful stem cell translation – Nurses, physicians and patient advocates Read More »

Stem cell headlines: half a genome, Australian snake oil, CRISPR patent battle

/ / 6 Comments
embryo-human

There’s a lot going on in the world of stem cells making for many striking headlines lately. Here are some stem cell headlines that caught my attention. Haploid Stem Cells Created. Could these cells be used to make germ cells? Charlatans and snake-oil salesmen ‘hijacking stem cell therapies’ in Australia In the CRISPR patent fight, the Broad Institute gains edge. The CRISPR-Cas9 patent

Stem cell headlines: half a genome, Australian snake oil, CRISPR patent battle Read More »

Weekend reads: sperm, stem cells, chimeras, STAP, DNA Apps

/
sperm-and-egg

Here are some cool science reads to enjoy this weekend. Lab-grown sperm made from stem cells can’t swim, but are able to fertilize eggs, reports Eric Boodman over at STAT. Mouse-human neural crest chimeras: Not only a matter of black and white. Clever title. Antonio Regalado writes about a DNA App Store coming soon to a

Weekend reads: sperm, stem cells, chimeras, STAP, DNA Apps Read More »

FDA meeting on stem cell regs: mostly who’s who of anti-regulation forces

/ / 16 Comments
FDAADF

The FDA in the past year or so has issued draft guidances on regulation of stem cells that would, if finalized, make it crystal clear that what many American stem cell clinics are selling are unapproved drugs. That would be a good thing for patients who are often being put at risk by many of

FDA meeting on stem cell regs: mostly who’s who of anti-regulation forces Read More »

TGIF weekend reads: stem cells, GMOs, #CRISPR, cats, cloning and more

/
cat-stem-cells

Sounds recommended weekend reads for you to enjoy since it is Friday and almost the weekend including stem cells, CRISPR, cats, cloning, and more. Holy GMO, China wants to buy Syngenta. RetractionWatch says that Macchiarini will soon be out at Karolinska. For more on this “super surgeon” who used stem cells, see here regarding recent Vanity

TGIF weekend reads: stem cells, GMOs, #CRISPR, cats, cloning and more Read More »

ViaCyte on the Rise: First Diabetes Trial Data & Acquires BetaLogics IP

/
VC-01-post-implant-final1-e1503703572933, viacyte

Clinical research on Type I Diabetes is one of the most exciting and promising areas of stem cells and regenerative medicine for human disease. Two of the coolest companies out there in this arena have been ViaCyte and BetaLogics (owned by J&J). For more on ViaCyte see my interview with President and CEO Paul Laikind

ViaCyte on the Rise: First Diabetes Trial Data & Acquires BetaLogics IP Read More »

Recommended weekend reading on stem cells & science

/ / 1 Comment
human-animal-chimeras

I try to catch up on my science reading over the weekends and evenings. Here’s my recommended weekend reading on stem cells & science. Did I miss anything especially cool? Let me know in the comments. Direct reprogramming of skin cells into insulin-producing cells. I love direct reprogramming. Healios and Athersys Enter Into Regenerative Medicine Partnership.

Recommended weekend reading on stem cells & science Read More »

Stem Cell News Briefs: Anversa, Japan Regs, Ocata Suit, More

/ / 3 Comments
Timothy-J.-Kieffer

It’s been a busy few weeks for the stem cell field. Below are some news briefs on developments. RetractionWatch reports that Piero Anversa is leaving Harvard/Brigham and Women’s Hospital after an investigation and dismissed lawsuit he filed against the institution. All still quiet on the STAP cell front at the same institutions. There’s some more

Stem Cell News Briefs: Anversa, Japan Regs, Ocata Suit, More Read More »